UK authority asks for director ban for Alliance Pharma CEO
pharmaphorum
SEPTEMBER 5, 2022
The UK Competition and Markets Authority (CMA) is seeking to disqualify Peter Butterfield, currently chief executive of Alliance Pharma, from serving as a company director. ” The action will only be heard if the Competition Appeal Tribunal (CAT) upholds the CMA’s findings against Alliance, it added. .”
Let's personalize your content